These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 17510243)
1. Human chorionic gonadotropin (hCG) up-regulates wnt5b and wnt7b in the mammary gland, and hCGbeta transgenic female mice present with mammary Gland tumors exhibiting characteristics of the Wnt/beta-catenin pathway activation. Kuorelahti A; Rulli S; Huhtaniemi I; Poutanen M Endocrinology; 2007 Aug; 148(8):3694-703. PubMed ID: 17510243 [TBL] [Abstract][Full Text] [Related]
2. The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis. Bachelot A; Carré N; Mialon O; Matelot M; Servel N; Monget P; Ahtiainen P; Huhtaniemi I; Binart N Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E845-52. PubMed ID: 23921141 [TBL] [Abstract][Full Text] [Related]
3. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Rulli SB; Kuorelahti A; Karaer O; Pelliniemi LJ; Poutanen M; Huhtaniemi I Endocrinology; 2002 Oct; 143(10):4084-95. PubMed ID: 12239120 [TBL] [Abstract][Full Text] [Related]
4. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha. Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494 [TBL] [Abstract][Full Text] [Related]
5. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Michaelson JS; Leder P Oncogene; 2001 Aug; 20(37):5093-9. PubMed ID: 11526497 [TBL] [Abstract][Full Text] [Related]
7. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression. Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310 [TBL] [Abstract][Full Text] [Related]
8. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution. Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346 [TBL] [Abstract][Full Text] [Related]
9. Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human chorionic gonadotropin. Rulli SB; Ahtiainen P; Mäkelä S; Toppari J; Poutanen M; Huhtaniemi I Endocrinology; 2003 Nov; 144(11):4980-90. PubMed ID: 12960071 [TBL] [Abstract][Full Text] [Related]
10. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853 [TBL] [Abstract][Full Text] [Related]
11. Integrin-interacting protein Kindlin-2 induces mammary tumors in transgenic mice. Li B; Chi X; Song J; Tang Y; Du J; He X; Sun X; Bi Z; Wang Y; Zhan J; Zhang H Sci China Life Sci; 2019 Feb; 62(2):225-234. PubMed ID: 30460471 [TBL] [Abstract][Full Text] [Related]
12. Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system. Silberstein GB; Van Horn K; Hrabeta-Robinson E; Compton J J Endocrinol; 2006 Aug; 190(2):225-39. PubMed ID: 16899557 [TBL] [Abstract][Full Text] [Related]
14. Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice. Lin TP; Guzman RC; Osborn RC; Thordarson G; Nandi S Cancer Res; 1992 Aug; 52(16):4413-9. PubMed ID: 1386556 [TBL] [Abstract][Full Text] [Related]
15. Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors. Yan L; Della Coletta L; Powell KL; Shen J; Thames H; Aldaz CM; MacLeod MC PLoS One; 2011 Jan; 6(1):e16515. PubMed ID: 21304988 [TBL] [Abstract][Full Text] [Related]
16. Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization. Yin YJ; Katz V; Salah Z; Maoz M; Cohen I; Uziely B; Turm H; Grisaru-Granovsky S; Suzuki H; Bar-Shavit R Cancer Res; 2006 May; 66(10):5224-33. PubMed ID: 16707447 [TBL] [Abstract][Full Text] [Related]
17. Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Humphreys RC; Lydon J; O'Malley BW; Rosen JM Mol Endocrinol; 1997 Jun; 11(6):801-11. PubMed ID: 9171243 [TBL] [Abstract][Full Text] [Related]
18. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729 [TBL] [Abstract][Full Text] [Related]
19. Androgen receptor inactivation resulted in acceleration in pubertal mammary gland growth, upregulation of ERα expression, and Wnt/β-catenin signaling in female mice. Gao YR; Walters KA; Desai R; Zhou H; Handelsman DJ; Simanainen U Endocrinology; 2014 Dec; 155(12):4951-63. PubMed ID: 25076121 [TBL] [Abstract][Full Text] [Related]
20. Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Benhaj K; Akcali KC; Ozturk M Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]